Should you buy, hold or sell Aurobindo Pharma (AUROPHARMA)?

Aurobindo Pharma trades on the NSE (India) market under the ticker AUROPHARMA, in the NSE-listed company space. If you're weighing whether AUROPHARMA looks like a buy, a hold, or one to avoid right now, checkthestock gives you two independent reads on the same screen: a technical read (what the price chart and momentum are doing) and a fundamental read (what the underlying business looks like on valuation, financial health, profitability and growth). The two don't always agree — and that disagreement is often the most useful thing to see before you act.

Short answer

There is no single permanent answer for Aurobindo Pharma — whether AUROPHARMA reads as a buy, hold or one to avoid changes as its price and published figures change. What this page does is show you the current read and the reasoning behind it, so you can judge it yourself rather than take a label on trust.

You get two independent scores: a technical read (0–10) from AUROPHARMA's own price chart — trend, momentum, RSI, MACD, moving averages — and a fundamental read (0–100) from published company figures covering valuation, financial health, profitability and growth. Where those two disagree, the page says so explicitly, because that disagreement is usually more informative than either score alone.

How to read it: a target price is shown only when AUROPHARMA's chart has real structure to project toward; for a sideways or falling chart no target is shown at all, because any number there would be guesswork. A suggested stop level is always shown, since risk matters either way. Figures are the latest available and may be delayed — see data sources and methodology.

Aurobindo Pharma (AUROPHARMA) — by the numbers

Fetching the latest company data…

Market cap

—

Revenue (TTM)

—

Profit margin

—

P/E

—

Analyst view

—

Next earnings

—

▶ Check AUROPHARMA now — free technical & fundamental read →

What you'll see when you check AUROPHARMA

The AUROPHARMA read is generated from live market data the moment you open it, so it reflects the current chart rather than a stale snapshot. On one screen you get:

A technical score (0–10) for Aurobindo Pharma, built from trend (moving averages), momentum (RSI, MACD), and strength (position in the 52-week range, volume).
A plain-English snapshot — is the trend up, down or sideways, is momentum healthy or stretched, and is this a sensible entry area or not.
Support, resistance and a reward-to-risk read derived from the actual chart structure — with an honest warning when there's no real support nearby to anchor a stop.
A fundamental read of the business behind AUROPHARMA: valuation, debt vs size, cash generation, profitability and growth — plus the recent earnings-vs-expectations record where analysts cover it.

Why two reads instead of one?

A great chart can sit on a shaky business, and a great business can have an ugly chart. Showing Aurobindo Pharma's technical and fundamental reads side by side means you can see which game you'd be playing with AUROPHARMA — a momentum trade, a value hold, or neither — instead of trusting a single number.

Common questions people search about AUROPHARMA

Is AUROPHARMA a good buy today?
AUROPHARMA technical analysis and RSI
Should I buy or sell AUROPHARMA?
Aurobindo Pharma share price outlook — buy, hold or sell?
AUROPHARMA support and resistance levels

The live read addresses each of these with data rather than opinion. It's educational information — not a personalised recommendation — and the same read is shown to every visitor worldwide.

▶ See the live AUROPHARMA read →

AUROPHARMA — frequently asked questions

Is AUROPHARMA a buy right now?

checkthestock generates an automated technical read on Aurobindo Pharma from the last 12 months of price data — trend, momentum (RSI, MACD), moving averages and relative strength — and pairs it with a fundamental read of the business. The result is a suggested buy, hold or sell framing, updated from live data when you check it. It is educational information, not personalised advice — the same read is shown to every visitor.

What technical indicators are used to score AUROPHARMA?

The technical read for Aurobindo Pharma uses RSI (momentum), MACD (momentum shift), the 20-, 50-, 100- and 200-day moving averages (trend), position in the 52-week range (strength), and volume versus its average. Each contributes to a 0–10 score, with the reasoning shown so you can judge it yourself.

Does the AUROPHARMA page show fundamentals too?

Yes. Alongside the chart read, Aurobindo Pharma's page shows a fundamental read: valuation (P/E, P/B), financial health (debt vs size, cash, free cash flow), profitability (ROE, margins) and growth — plus, where analysts cover it, the recent record of earnings versus expectations. A strong chart on a weak business (or the reverse) is flagged clearly.

Related NSE stocks to check

Learn the signals behind the read

Educational only — not financial advice. checkthestock provides automated, educational analysis of Aurobindo Pharma (AUROPHARMA) generated from public market data using technical indicators and published fundamentals. It is not a recommendation to buy or sell any security, and is identical for every visitor. Markets carry risk; do your own research and consult a licensed financial adviser before investing.

← Browse all stocks · Good Picks → · Check any stock →

About · How these reads are calculated · Data sources · Privacy · Terms